Cholesterol oxidation in the retina: Implications of 7KCh formation in chronic inflammation and age-related macular degeneration

Journal of Lipid Research

Volumn 51, Issue 10, 2010, Pages 2847-2862

  Rodríguez, Ignacio R ^a   Larrayoz, Ignacio M ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

7 ketocholesterol; Cytokines; Oxysterols

Indexed keywords

7 OXOCHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPROTEIN; OXYSTEROL; SULFOTRANSFERASE; VASCULOTROPIN;

CELL DEATH; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENETIC ASSOCIATION; HUMAN; LIPID OXIDATION; LIPID STORAGE; MOLECULAR MECHANICS; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SULFATION;

ANIMALS; CELL DEATH; CHOLESTEROL; HUMANS; INFLAMMATION; KETOCHOLESTEROLS; MACULAR DEGENERATION; OXIDATION-REDUCTION; RETINA;

EID: 77956800486     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R004820     Document Type: Review

References (147)

1. Lordan, S., J. J. Mackrill, and N. M. O'Brien. 2009. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J. Nutr. Biochem. 20: 321-336.
2. Poli, G., B. Sottero, S. Gargiulo, and G. Leonarduzzi. 2009. Cholesterol oxidation products in the vascular remodeling due to atherosclerosis. Mol. Aspects Med. 30: 180-189.
3. Vejux, A., and G. Lizard. 2009. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol. Aspects Med. 30: 153-170.
4. Töröcsik, D., A. Szanto, and L. Nagy. 2009. Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages. Mol. Aspects Med. 30: 134-152.
5. Björkhem, I., A. Cedazo-Minguez, V. Leoni, and S. Meaney. 2009. Oxysterols and neurodegenerative diseases. Mol. Aspects Med. 30: 171-179.
6. Olkkonen, V. M., and R. Hynynen. 2009. Interactions of oxysterols with membranes and proteins. Mol. Aspects Med. 30: 123-133.
7. Brown, A. J., and W. Jessup. 2009. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol. Aspects Med. 30: 111-122.
8. Joffre, C., L. Leclere, B. Buteau, L. Martine, S. Cabaret, L. Malvitte, N. Acar, G. Lizard, A. Bron, C. Creuzot-Garcher, et al. 2007. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr. Eye Res. 32: 271-280.
9. Moreira, E. F., I. M. Larrayoz, J. W. Lee, and I. R. Rodriguez. 2009. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Invest. Ophthalmol. Vis. Sci. 50: 523-532.
10. Rodriguez, I. R., and S. J. Fliesler. 2009. Photodamage generates 7-keto-and 7-hydroxycholesterol in the rat retina via a free radical-mediated mechanism. Photochem. Photobiol. 85: 1116-1125.
11. Yu, D. Y., and S. J. Cringle. 2001. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog. Retin. Eye Res. 20: 175-208.
12. Gordon, W. C., N. G. Bazan. 1997. Cellular organization and biochemistry of the retina. Chapman and Hall, London.
13. Fliesler, S. J., and R. E. Anderson. 1983. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 22: 79-131.
14. Gordiyenko, N., M. Campos, J. W. Lee, R. N. Fariss, J. Sztein, and I. R. Rodriguez. 2004. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities in vitro and in vivo. Invest. Ophthalmol. Vis. Sci. 45: 2822-2829.
15. Tserentsoodol, N., J. Sztein, M. Campos, N. V. Gordiyenko, R. N. Fariss, J. W. Lee, S. J. Fliesler, and I. R. Rodriguez. 2006. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol. Vis. 12: 1306-1318.
16. Fliesler, S. J., R. Florman, L. M. Rapp, S. J. Pittler, and R. K. Keller. 1993. In vivo biosynthesis of cholesterol in the rat retina. FEBS Lett. 335: 234-238.
17. Tserentsoodol, N., N. V. Gordiyenko, I. Pascual, J. W. Lee, S. J. Fliesler, and I. R. Rodriguez. 2006. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 12: 1319-1333.
18. Oyster, W. C., editor. 1999. The Human Eye: Structure and Function. Sinauer Associates, Sunderland, MA. 595-699.
19. Berger, J. W., S. L. Fine, and M. G. Maguire. 1999. Age-Related Macular Degeneration. Mosby, Inc. St. Louis, MO.
20. Chakravarthy, U., J. Evans, and P. J. Rosenfeld. 2010. Age related macular degeneration. BMJ. 340: c981.
21. Morohoshi, K., A. M. Goodwin, M. Ohbayashi, and S. J. Ono. 2009. Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J. Autoimmun. 33: 247-254.
22. Ozkiris, A. 2010. Anti-VEGF agents for age-related macular degeneration. Expert Opin. Ther. Pat. 20: 103-118.
23. Hakamata, H., A. Miyazaki, M. Sakai, Y. I. Sakamoto, and S. Horiuchi. 1998. Cytotoxic effect of oxidized low density lipoprotein on macrophages. J. Atheroscler. Thromb. 5: 66-75.
24. Seimon, T., and I. Tabas. 2009. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50 ( Suppl. ): S382-S387.
25. Tabas, I. 2010. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10: 36-46.
26. Rodriguez, I. R., S. Alam, and J. W. Lee. 2004. Cytotoxicity of oxidized low-density lipoprotein in cultured RPE cells is dependent on the formation of 7-ketocholesterol. Invest. Ophthalmol. Vis. Sci. 45: 2830-2837.
27. Dzeletovic, S., A. Babiker, E. Lund, and U. Diczfalusy. 1995. Time course of oxysterol formation during in vitro oxidation of low density lipoprotein. Chem. Phys. Lipids. 78: 119-128.
28. Brown, A. J., R. T. Dean, and W. Jessup. 1996. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J. Lipid Res. 37: 320-335.
29. Smith, L. 1990. Mechanisms of formation of oxysterols: a general survey. In Free Radicals, Lipoproteins, and Membrane Lipids. A. Crastes de Paulet, L. Douste-Blazy, L. Paoletti, editors. Plenum Press, New York. 115-132.
30. Smith, L. L. 1996. Review of progress in sterol oxidations: 1987- 1995. Lipids. 31: 453-487.
31. Wielkoszynski, T., K. Gawron, J. Strzelczyk, P. Bodzek, M. Zalewska-Ziob, G. Trapp, M. Srebniak, and A. Wiczkowski. 2006. Cellular toxicity of oxycholesterols. Bioessays. 28: 387-398.
32. Norlin, M., and K. Wikvall. 2007. Enzymes in the conversion of cholesterol into bile acids. Curr. Mol. Med. 7: 199-218.
33. Smith, L. L., J. I. Teng, M. J. Kulig, and F. L. Hill. 1973. Sterol metabolism XXIII. Cholesterol oxidation by radiation-induced processes. J. Org. Chem. 38: 1763-1765.
34. Girotti, A. W. 2001. Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J Photochem. Photobiol B. 63: 103-113.
35. Korytowski, W., G. J. Bachowski, and A. W. Girotti. 1992. Photoperoxidation of cholesterol in homogeneous solution, isolated membranes, and cells: comparison of the 5 alpha-and 6 beta-hydroperoxides as indicators of singlet oxygen intermediacy. Photochem. Photobiol. 56: 1-8.
36. Thomas, J. P., R. D. Hall, and A. W. Girotti. 1987. Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. Cancer Lett. 35: 295-302.
37. Cheng, Y. W., J. J. Kang, Y. L. Shih, Y. L. Lo, and C. F. Wang. 2005. Cholesterol-3-beta, 5-alpha, 6-beta-triol induced genotoxicity through reactive oxygen species formation. Food Chem. Toxicol. 43: 617-622.
38. Van Reyk, D. M., A. J. Brown, L. M. Hult'en, R. T. Dean, and W. Jessup. 2006. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep. 11: 255-262.
39. Björkhem, I., O. Andersson, U. Diczfalusy, B. Sevastik, R. J. Xiu, C. Duan, and E. Lund. 1994. Atherosclerosis and sterol 27- hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91: 8592-8596.
40. Luoma, P. V. 2008. Cytochrome P450s and gene activation-from pharmacology to cholesterol elimination and regression of atherosclerosis. Eur. J. Pharmacol. 64: 841-850.
41. Lund, E. G., T. A. Kerr, J. Sakai, W. P. Li, and D. W. Russell. 1998. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 273: 34316-34327.
42. Wu, Z., K. O. Martin, N. B. Javitt, and J. Y. Chiang. 1999. Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. J. Lipid Res. 40: 2195-2203.
43. Li-Hawkins, J., E. G. Lund, A. D. Bronsons, and D. W. Russell. 2000. Expression cloning of an oxysterol 7α-hydroxylase selective for 24-hydroxycholesterol. J. Biol. Chem. 275: 16543-16549.
44. Ikeda, H., M. Ueda, M. Ikeda, H. Kobayashi, and Y. Honda. 2003. Oxysterol 7α-hydroxylase (CYP39A1) in the ciliary non-pigmented epithelium of bovine eye. Lab. Invest. 83: 349-355.
45. Bretillon, L., U. Diczfalusy, I. Bjorkhem, M. A. Maire, L. Martine, C. Joffre, N. Acar, A. Bron, and C. Creuzot-Garcher. 2007. Cholesterol-24S- hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 32: 361-366.
46. Pawlak, A., M. Wrona, M. Rozanowska, M. Zareba, L. E. Lamb, J. E. Roberts, J. D. Simon, and T. Sarna. 2003. Comparison of the aerobic photoreactivity of A2E with its precursor retinal. Photochem. Photobiol. 77: 253-258.
47. Harper, W. S., and E. R. Gaillard. 2001. Studies of all-trans-retinal as a photooxidizing agent. Photochem. Photobiol. 73: 71-76.
48. Rozanowska, M., and T. Sarna. 2005. Light-induced damage to the retina: role of rhodopsin chromophore revisited. Photochem. Photobiol. 81: 1305-1330.
49. Yefimova, M. G., J. C. Jeanny, X. Guillonneau, N. Keller, J. Nguyen-Legros, C. Sergeant, F. Guillou, and Y. Courtois. 2000. Iron, ferritin, transferrin, and transferrin receptor in the adult rat retina. Invest. Ophthalmol. Vis. Sci. 41: 2343-2351.
50. Hahn, P., T. Dentchev, Y. Qian, T. Rouault, Z. L. Harris, and J. L. Dunaief. 2004. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina. Mol. Vis. 10: 598-607.
51. Ohishi, K., X. M. Zhang, S. Moriwaki, T. Hiramitsu, and S. Matsugo. 2005. Iron release analyses from ferritin by visible light irradiation. Free Radic. Res. 39: 875-882.
52. Ohishi, K., X. M. Zhang, S. Moriwaki, T. Hiramitsu, and S. Matsugo. 2006. In the presence of ferritin, visible light induces lipid peroxidation of the porcine photoreceptor outer segment. Free Radic. Res. 40: 799-807.
53. Yurkova, I., D. Huster, and J. Arnhold. 2009. Free radical fragmentation of cardiolipin by cytochrome c. Chem. Phys. Lipids. 158: 16-21.
54. Bazan, N. G., W. C. Gordon, and E. B. Rodriguez de Turco. 1992. Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Adv. Exp. Med. Biol. 318: 295-306.
55. Wang, N., and R. E. Anderson. 1993. Transport of 22:6n-3 in the plasma and uptake into retinal pigment epithelium and retina. Exp. Eye Res. 57: 225-233.
56. Elner, V. M. 2002. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans. Am. Ophthalmol. Soc. 100: 301-338.
57. Miller, J. W., A. W. Walsh, M. Kramer, T. Hasan, N. Michaud, T. J. Flotte, R. Haimovici, and E. S. Gragoudas. 1995. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch. Ophthalmol. 113: 810-818.
58. Haimovici, R., M. Kramer, J. W. Miller, T. Hasan, T. J. Flotte, K. T. Schomacker, and E. S. Gragoudas. 1997. Localization of lipoprotein- delivered benzoporphyrin derivative in the rabbit eye. Curr. Eye Res. 16: 83-90.
59. Hayes, K. C., S. Lindsey, Z. F. Stephan, and D. Brecker. 1989. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest. Ophthalmol. Vis. Sci. 30: 225-232.
60. Noske, U. M., U. Schmidt-Erfurth, C. Meyer, and H. Diddens. 1998. Lipid metabolism in retinal pigment epithelium. Possible significance of lipoprotein receptors. Ophthalmologe. 95: 814-819.
61. Scheidt, H. A., P. Muller, A. Herrmann, and D. Huster. 2003. The potential of fluorescent and spin-labeled steroid analogs to mimic natural cholesterol. J. Biol. Chem. 278: 45563-45569.
62. Schmidt-Erfurth, U., M. Rudolf, M. Funk, C. Hofmann-Rummelt, N. S. Franz-Haas, Z. Aherrahrou, and U. Schlötzer-Schrehardt. 2008. Ultrastructural changes in a murine model of graded Bruch membrane lipoidal degeneration and corresponding VEGF164 detection. Invest. Ophthalmol. Vis. Sci. 49: 390-398.
63. Hu, W., A. Jiang, J. Liang, H. Meng, B. Chang, H. Gao, and X. Qiao. 2008. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Invest. Ophthalmol. Vis. Sci. 49: 407-415.
64. Sima, A. V., C. S. Stancu, and M. Simionescu. 2009. Vascular endothelium in atherosclerosis. Cell Tissue Res. 335: 191-203.
65. Lee, J. W., H. Fuda, N. B. Javitt, C. A. Strott, and I. R. Rodriguez. 2006. Expression and localization of sterol 27-hydroxylase (CYP27A1) in monkey retina. Exp. Eye Res. 83: 465-469.
66. Cali, J. J., C. L. Hsieh, U. Francke, and D. W. Russel. 1991. Mutations in the bile acid biosynthetic enzyme sterol-27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 266: 7779-7783.
67. Dotti, M. T., A. Rufa, and A. Federico. 2001. Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings. J. Inherit. Metab. Dis. 24: 696-706.
68. Ramirez, D. M., S. Andersson, and D. W. Russell. 2008. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 507: 1676-1693.
69. Pikuleva, I. A. 2008. Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering. Expert Opin. Drug Metab. Toxicol. 4: 1403-1414.
70. Lyons, M. A., and A. J. Brown. 2001. Metabolism of an oxysterol, 7-ketocholesterol, by sterol 27-hydroxylase in HepG2 cells. Lipids. 36: 701-711.
71. Brown, A. J., G. F. Watts, J. R. Burnett, R. T. Dean, and W. Jessup. 2000. Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture. J. Biol. Chem. 275: 27627-27633.
72. Jessup, W., and A. J. Brown. 2005. Novel routes for metabolism of 7-ketocholesterol. Rejuvenation Res. 8: 9-12.
73. Bjorkhem, I. 2006. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 260: 493-508.
74. Russell, D. W., R. W. Halford, D. M. Ramirez, R. Shah, and T. Kotti. 2009. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 78: 1017-1040.
75. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA. 96: 266-271.
76. Baranowski, M. 2008. Biological role of liver X receptors. J. Physiol. Pharmacol. 59 ( Suppl 7 ): 31-55.
77. Terasaka, N., N. Wang, L. Yvan-Charvet, and A. R. Tall. 2007. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. USA. 104: 15093-15098.
78. Tall, A. R., L. Yvan-Charvet, N. Terasaka, T. Pagler, and N. Wang. 2008. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 7: 365-375.
79. Tall, A. R. 2008. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med. 263: 256-273.
80. Jaworski, C. J., E. Moreira, A. Li, R. Lee, and I. R. Rodriguez. 2001. A family of 12 human genes containing oxysterol-binding domains. Genomics. 78: 185-196.
81. Moreira, E. F., C. Jaworski, A. Li, and I. R. Rodriguez. 2001. Molecular and biochemical characterization of a novel oxysterol-binding protein (OSBP2) highly expressed in retina. J. Biol. Chem. 276: 18570-18578.
82. Fairn, G. D., and C. R. McMaster. 2008. Emerging roles of the oxysterol-binding protein family in metabolism, transport, and signaling. Cell. Mol. Life Sci. 65: 228-236.
83. Ishida, B. Y., K. G. Duncan, K. R. Bailey, J. P. Kane, and D. M. Schwartz. 2006. High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture. Br. J. Ophthalmol. 90: 616-620.
84. Lyons, M. A., S. Samman, L. Gatto, and A. J. Brown. 1999. Rapid hepatic metabolism of 7-ketocholesterol in vivo: implications for dietary oxysterols. J. Lipid Res. 40: 1846-1857.
85. Lyons, M. A., and A. J. Brown. 2001. 7-Ketocholesterol delivered to mice in chylomicron remnant-like particles is rapidly metabolised, excreted and does not accumulate in aorta. Biochim. Biophys. Acta. 1530: 209-218.
86. Fuda, H., N. B. Javitt, K. Mitamura, S. Ikegawa, and C. A. Strott. 2007. Oxysterols are substrates for cholesterol sulfotransferase. J. Lipid Res. 48: 1343-1352.
87. Falany, C. N., D. He, N. Dumas, A. R. Frost, and J. L. Falany. 2006. Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization. J. Steroid Biochem. Mol. Biol. 102: 214-221.
88. Sleer, L. S., A. J. Brown, and K. K. Stanley. 2001. Interaction of caveolin with 7-ketocholesterol. Atherosclerosis. 159: 49-55.
89. Taylor, F. R., and A. A. Kandutsch. 1985. Oxysterol binding protein. Chem. Phys. Lipids. 38: 187-194.
90. Wang, C., L. JeBailey, and N. D. Ridgway. 2002. Oxysterol-bindingprotein (OSBP)-related protein 4 binds 25-hydroxycholesterol and interacts with vimentin intermediate filaments. Biochem. J. 361: 461-472.
91. Lyons, M. A., and A. J. Brown. 1999. 7-Ketocholesterol. Int. J. Biochem. Cell Biol. 31: 369-375.
92. Jessup, W., P. Wilson, K. Gaus, and L. Kritharides. 2002. Oxidized lipoproteins and macrophages. Vascul. Pharmacol. 38: 239-248.
93. Erridge, C., D. J. Webb, and C. M. Spickett. 2007. Toll-like receptor 4 signalling is neither sufficient nor required for oxidised phospholipid mediated induction of interleukin-8 expression. Atherosclerosis. 193: 77-85.
94. Lee, C. S., E. H. Joe, and I. Jou. 2006. Oxysterols suppress inducible nitric oxide synthase expression in lipopolysaccharidestimulated astrocytes through liver X receptor. Neuroreport. 17: 183-187.
95. Lemaire, S., G. Lizard, S. Monier, C. Miguet, S. Gueldry, F. Volot, P. Gambert, and D. Neel. 1998. Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett. 440: 434-439. (Pubitemid 29052329)
96. Luthra, S., J. Dong, A. L. Gramajo, M. Chwa, D. W. Kim, A. Neekhra, B. D. Kuppermann, and M. C. Kenney. 2008. 7-Ketocholesterol activates caspases-3/7,-8, and-12 in human microvascular endothelial cells in vitro. Microvasc. Res. 75: 343-350.
97. Dulak, J., A. Jozkowicz, W. Dichtl, H. Alber, S. P. Schwarzacher, O. Pachinger, and F. Weidinger. 2001. Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation. Atherosclerosis. 159: 325-332.
98. Lee, H. S., J. S. Chang, J. A. Baek, M. Y. Chung, H. C. Lee, B. Y. Rhim, D. E. Sok, M. C. Rho, Y. K. Kim, and K. Kim. 2005. TNFalpha activates death pathway in human aorta smooth muscle cell in the presence of 7-ketocholesterol. Biochem. Biophys. Res. Commun. 333: 1093-1099.
99. Agrawal, S., M. L. Agarwal, M. Chatterjee-Kishore, G. R. Stark, and G. M. Chisolm. 2002. Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Mol. Cell. Biol. 22: 1981-1992.
100. Chang, J. Y., and L. Z. Liu. 1998. Toxicity of cholesterol oxides on cultured neuroretinal cells. Curr. Eye Res. 17: 95-103.
101. Ong, J. M., A. M. Aoki, G. M. Seigel, I. Sacerio, R. Castellon, A. B. Nesburn, and M. C. Kenney. 2003. Oxysterol-induced toxicity in R28 and ARPE-19 cells. Neurochem. Res. 28: 883-891.
102. Ramos, M. A., M. Kuzuya, T. Esaki, S. Miura, S. Satake, T. Asai, S. Kanda, T. Hayashi, and A. Iguchi. 1998. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 18: 1188-1196.
103. Sung, S. C., K. Kim, K. A. Lee, K. H. Choi, S. M. Kim, Y. H. Son, Y. S. Moon, S. K. Eo, and B. Y. Rhim. 2009. 7-Ketocholesterol upregulates interleukin-6 via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells. J. Vasc. Res. 46: 36-44.
104. Terkeltaub, R., C. L. Banka, J. Solan, D. Santoro, K. Brand, and L. K. Curtiss. 1994. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler. Thromb. 14: 47-53.
105. Liu, Y., L. M. Hulten, and O. Wiklund. 1997. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler. Thromb. Vasc. Biol. 17: 317-323.
106. Erridge, C., D. J. Webb, and C. M. Spickett. 2007. 25-Hydroxycholesterol, 7beta-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic. Res. 41: 260-266.
107. Napolitano, M., and E. Bravo. 2005. Lipid metabolism and TNFalpha secretion in response to dietary sterols in human monocyte derived macrophages. Eur. J. Clin. Invest. 35: 482-490.
108. Pedruzzi, E., C. Guichard, V. Ollivier, F. Driss, M. Fay, C. Prunet, J. C. Marie, C. Pouzet, M. Samadi, C. Elbim, et al. 2004. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24: 10703-10717.
109. Palozza, P., S. Serini, S. Verdecchia, M. Ameruso, S. Trombino, N. Picci, G. Monego, and F. O. Ranelletti. 2007. Redox regulation of 7-ketocholesterol- induced apoptosis by beta-carotene in human macrophages. Free Radic. Biol. Med. 42: 1579-1590.
110. Naito, Y., M. Shimozawa, H. Manabe, N. Nakabe, K. Katada, S. Kokura, N. Yoshida, H. Ichikawa, T. Kon, and T. Yoshikawa. 2006. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species. Eur. J. Pharmacol. 546: 11-18.
111. Choi, G. S., H. J. Park, G. Y. Hur, S. J. Choi, S. Y. Shin, Y. M. Ye, and H. S. Park. 2009. Vascular endothelial growth factor in allergen- induced nasal inflammation. Clin. Exp. Allergy. 39: 655-661.
112. Krishnamurthy, P., J. Rajasingh, E. Lambers, G. Qin, D. W. Losordo, and R. Kishore. 2009. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ. Res. 104: e9-e18.
113. Ingueneau, C., U. Huynh-Do, B. Marcheix, A. Athias, P. Gambert, A. Negre-Salvayre, R. Salvayre, and C. Vindis. 2009. TRPC1 is regulated by caveolin-1 and is involved in oxidized LDL-induced apoptosis of vascular smooth muscle cells. J. Cell. Mol. Med. 13: 1620-1631.
114. Song, C., R. A. Hiipakka, and S. Liao. 2001. Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis. Steroids. 66: 473-479.
115. Taylor, C. T. 2008. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem. J. 409: 19-26.
116. Xia, C., Q. Meng, L. Z. Liu, Y. Rojanasakul, X. R. Wang, and B. H. Jiang. 2007. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 67: 10823-10830.
117. Larrayoz, I. M., J-D. Huang, J-W. Lee, I. Pascual, and I. R. Rodriguez. 2010. 7-Ketocholesterol-induced inflammation is mediated by multiple kinase signaling pathways via NF κB but independently of reactive oxygen species formation. Invest. Ophthalmol. Vis. Sci. Epub ahead of print. June 16, 2010.
118. McCourt, M. P., K. Ashraf, R. Miller, C. M. Weeks, N. Li, W. Pangborn, and D. L. Dorset. 1997. X-ray crystal structure of cytotoxic oxidized cholesterols: 7-ketocholesterol and 25-hydroxycholesterol. J. Lipid Res. 38: 1014-1021.
119. Phillips, J. E., Y. J. Geng, and R. P. Mason. 2001. 7-Ketocholesterol forms crystalline domains in model membranes and murine aortic smooth muscle cells. Atherosclerosis. 159: 125-135.
120. Massey, J. B. 2006. Membrane and protein interactions of oxysterols. Curr. Opin. Lipidol. 17: 296-301.
121. Lemaire-Ewing, S., C. Prunet, T. Montange, A. Vejux, A. Berthier, G. Bessede, L. Corcos, P. Gambert, D. Neel, and G. Lizard. 2005. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 21: 97-114.
122. Zhang, C., J. Baffi, S. W. Cousins, and K. G. Csaky. 2003. Oxidantinduced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. J. Cell Sci. 116: 1915-1923.
123. Prunet, C., S. Lemaire-Ewing, F. Menetrier, D. Neel, and G. Lizard. 2005. Activation of caspase-3-dependent and-independent pathways during 7-ketocholesterol-and 7beta-hydroxycholesterol-induced cell death: a morphological and biochemical study. J. Biochem. Mol. Toxicol. 19: 311-326.
124. Panini, S. R., L. Yang, A. E. Rusinol, M. S. Sinensky, J. V. Bonvetre, and C. C. Leslie. 2001. Arichidonate metabolism and signaling pathway of induction of apoptosis by oxidized LDL/oxysterol. J. Lipid Res. 42: 1678-1686.
125. Akiba, S., Y. Yoneda, S. Ohno, M. Nemoto, and T. Sato. 2003. Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification. J. Lipid Res. 44: 1676-1685. (Pubitemid 37185878)
126. Akiba, S., H. Ii, Y. Yoneda, and T. Sato. 2004. Translocation of phospholipase A2 to membranes by oxidized LDL and hydroxyoctadecadienoic acid to contribute to cholesteryl ester formation. Biochim. Biophys. Acta. 1686: 77-84.
127. Freeman, N. E., A. E. Rusinol, M. R. Linton, D. L. Hachey, S. Fazio, M. S. Sinensky, and D. Thewke. 2005. Acyl-coenzyme A: cholesterol acyltransferase promotes oxidized LDL/oxysterol-induced apoptosis in macrophages. J. Lipid Res. 46: 1933-1943.
128. Ishizuka, T., J. Cheng, H. Sing, M. D. Vitto, V. L. Manthati, J. R. Flack, and M. Laniado-Schwartzman. 2008. 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-κB activation and the production of inflammatory cytokines in human endothelial cells. J. Pharmacol. Exp. Ther. 324: 103-110.
129. Ghelli, A., A. M. Porcelli, C. Zanna, and M. Rugolo. 2002. 7-Ketocholesterol and staurosporine induce opposite changes in intracellular pH, associated with distinct types of cell death in ECV304 cells. Arch. Biochem. Biophys. 402: 208-217.
130. Malvitte, L., T. Montange, A. Vejux, C. Joffre, A. Bron, C. Creuzot-Garcher, and G. Lizard. 2008. Activation of a caspase- 3-independent mode of cell death associated with lysosomal destabilization in cultured human retinal pigment epithelial cells (ARPE-19) exposed to 7beta-hydroxycholesterol. Curr. Eye Res. 33: 769-781.
131. Buytaert, E., G. Callewaert, N. Hendrickx, L. Scorrano, D. Hartmann, L. Missiaen, J. R. Vandenheede, I. Heirman, J. Grooten, and P. Agostinis. 2006. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J. 20: 756-758.
132. Kritharides, L., M. Kus, A. J. Brown, W. Jessup, and R. T. Dean. 1996. Hydroxypropyl-beta-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells. J. Biol. Chem. 271: 27450-27455.
133. Riazy, M., J. H. Chen, and U. P. Steinbrecher. 2009. VEGF secretion by macrophages is stimulated by lipid and protein components of OxLDL via PI3-kinase and PKCzeta activation and is independent of OxLDL uptake. Atherosclerosis. 204: 47-54.
134. Boullier, A., P. Friedman, R. Harkewicz, K. Hartvigsen, S. R. Green, F. Almazan, E. A. Dennis, D. Steinberg, J. L. Witztum, and O. Quehenberger. 2005. Phosphocholine as a pattern recognition ligand for CD36. J. Lipid Res. 46: 969-976.
135. Ogura, S., A. Kakino, Y. Sato, Y. Fujita, S. Iwamoto, K. Otsui, R. Yoshimoto, and T. Sawamura. 2009. LOX-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ. J. 73: 1993-1999.
136. Rhainds, D., and L. Brissette. 2004. The role of scavenger receptors class B type I (SRBI) in lipid trafficking: defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36: 39-77.
137. Curcio, C. A., C. L. Millican, T. Bailey, and H. S. Kruth. 2001. Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 42: 265-274.
138. Ruberti, J. W., C. A. Curcio, C. L. Millican, B. P. Menco, J. D. Huang, and M. Johnson. 2003. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 44: 1753-1759.
139. Rudolf, M., and C. A. Curcio. 2009. Esterified cholesterol is highly localized to bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem. 57: 731-739.
140. Malek, G., C. M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio. 2003. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 162: 413-425.
141. Curcio, C. A., J. B. Presley, C. L. Millican, and N. E. Medeiros. 2005. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye Res. 80: 761-775.
142. Anderson, D. H., R. F. Mullins, G. S. Hageman, and L. V. Johnson. 2002. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134: 411-431.
143. Handa, J. T. 2007. New molecular histopathologic insights into the pathogenesis of age-related macular degeneration. Int. Ophthalmol. Clin. 47: 15-50.
144. SanGiovanni, J. P., S. Mehta, and S. Mehta. 2009. Variation in lipid-associated genes as they relate to risk of advanced age-related macular degeneration. World Rev. Nutr. Diet. 99: 105-158.
145. Torrini, M., C. Marchese, M. Vanzetti, V. Marini, P. Origone, C. Garre, and C. Mareni. 2007. Mutation analysis of oxisterol-binding- protein gene in patients with age-related macular degeneration. Genet. Test. 11: 421-426.
146. Chen, W., D. Stambolian, A. O. Edwards, K. E. Branhamd, M. Othmand, J. Jakobsdottire, N. Tosakulwongc, M. A. Pericak-Vancef, P. A. Campochiarog, M. L. Klein, et al. 2010. Genetic variants near TIMP3 and HDL-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA. 107:7401-7406.
147. Neale, B. M., J. Fagerness, R. Reynolds, L. Sobrin, M. Parker, S Raychaudhuri, P. L. Tan, E. C. Oh, J. E. Merriam, E. Souied, et al. 2010. Genome-wide association study of advanced agerelated macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc. Natl. Acad. Sci. USA. 107: 7395-7400.